Several analysts have recently updated their ratings and price targets for Stryker (NYSE: SYK):
- 8/8/2026 – Stryker was upgraded by Wall Street Zen from “hold” to “buy”.
- 8/3/2026 – Stryker had its “outperform” rating reaffirmed by Citigroup Inc..
- 8/3/2026 – Stryker had its price target lowered by Citizens Jmp from $440.00 to $400.00. They now have a “market outperform” rating on the stock.
- 7/31/2026 – Stryker had its “hold (c)” rating reaffirmed by Weiss Ratings.
- 7/31/2026 – Stryker had its price target lowered by Royal Bank Of Canada from $435.00 to $420.00. They now have an “outperform” rating on the stock.
- 7/31/2026 – Stryker was given a new $370.00 price target by Raymond James Financial, Inc..
- 7/31/2026 – Stryker had its price target lowered by Piper Sandler from $420.00 to $390.00. They now have an “overweight” rating on the stock.
- 7/31/2026 – Stryker was given a new $375.00 price target by Wolfe Research.
- 7/31/2026 – Stryker had its price target lowered by JPMorgan Chase & Co. from $400.00 to $350.00. They now have an “overweight” rating on the stock.
- 7/31/2026 – Stryker had its price target raised by Truist Financial Corporation from $330.00 to $340.00. They now have a “hold” rating on the stock.
- 7/31/2026 – Stryker had its price target lowered by BTIG Research from $371.00 to $358.00. They now have a “buy” rating on the stock.
- 7/28/2026 – Stryker is now covered by UBS Group AG. They set a “buy” rating and a $400.00 price target on the stock.
- 7/28/2026 – Stryker is now covered by UBS Group AG. They set a “buy” rating and a $400.00 price target on the stock.
- 7/13/2026 – Stryker was given a new $371.00 price target by BTIG Research.
- 7/9/2026 – Stryker was given a new $370.00 price target by Argus.
- 7/8/2026 – Stryker is now covered by BMO Capital Markets. They set an “outperform” rating and a $369.00 price target on the stock.
- 7/8/2026 – Stryker was upgraded by BMO Capital Markets to “strong-buy”.
- 7/6/2026 – Stryker was given a new $350.00 price target by Evercore Inc.
Stryker Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. Stryker’s payout ratio is currently 36.48%.
Insiders Place Their Bets
In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the sale, the director owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. The trade was a 13.87% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the transaction, the vice president owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This represents a 30.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.60% of the company’s stock.
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
See Also
- Five stocks we like better than Stryker
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
